Our findings provide evidence that T cell-derived activation or selection signals, in particular CD40L, shape the BCR repertoire of CLL in IgH.TEμ mice, but do not significantly affect disease onset or progression. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.